Synonyms: WEHI 164, WEHI164, WEHI 164 TC
WEHI-164 is a mouse fibrosarcoma cell line derived from a tumor induced by subcutaneous injections of 3-methylcholanthrene(1). The model is suitable for efficacy and PD testing of anti-cancer immunotherapeutics in vivo. At CrownBio, the WEHI-164 model is available subcutaneously.
Summary | |
---|---|
Cancer Type | Fibrosarcoma |
Subtype | N/A |
Mouse Strain | BALB/c |
TMA | TMA-CP-SY-008 |
(1) Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells. Proc. Soc. Exp. Biol. Med. 144:813-818, 1973.